MindWalk Holdings (HYFT) Shares Issued (2020 - 2026)
MindWalk Holdings (HYFT) posted quarterly Shares Issued of $3.0 million for Q1 2026, down 72.67% year-over-year from $11.1 million in Q1 2025, and little changed quarter-over-quarter from $3.0 million in Q4 2025.
MindWalk Holdings (HYFT) Shares Issued (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Shares Issued for 7 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued fell 72.67% year-over-year to $3.0 million; the TTM figure through Jan 2026 stood at $3.0 million (down 72.67% YoY), while the FY2025 annual figure was $12.2 million, up 7.86% from the prior year.
- Shares Issued was little changed at $3.0 million in Q1 2026 per HYFT's latest filing, from $3.0 million in the prior quarter.
- Across five years, Shares Issued topped out at $12.5 million in Q1 2024 and bottomed at $2.6 million in Q3 2022.
- Historically, Shares Issued has averaged $7.7 million across 5 years, with a median of $7.7 million in 2023.
- Annual changes were most pronounced in 2023 — Shares Issued jumped 239.39% — and 2025, when it plunged 73.71%.
- MindWalk Holdings' Shares Issued stood at $6.9 million in 2022, then gained by 26.68% to $8.7 million in 2023, then jumped by 32.7% to $11.5 million in 2024, then slumped by 73.71% to $3.0 million in 2025, then slipped by 0.07% to $3.0 million in 2026.
- Business Quant data shows HYFT's Shares Issued at $3.0 million in Q1 2026, $3.0 million in Q4 2025, and $12.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 3.03 Mn |
| Jan 31, 2026 | 3.03 Mn |
| Oct 31, 2025 | 3.03 Mn |
| Oct 31, 2025 | 3.03 Mn |
| Apr 30, 2025 | 11.98 Mn |
| Apr 30, 2025 | 11.98 Mn |
| Jan 31, 2025 | 11.08 Mn |
| Jan 31, 2025 | 11.08 Mn |
| Oct 31, 2024 | 11.52 Mn |
| Oct 31, 2024 | 11.52 Mn |
| Apr 30, 2024 | 11.29 Mn |
| Apr 30, 2024 | 11.29 Mn |
| Jan 31, 2024 | 12.49 Mn |
| Jan 31, 2024 | 12.49 Mn |
| Oct 31, 2023 | 8.68 Mn |
| Oct 31, 2023 | 8.68 Mn |
| Jul 31, 2023 | 8.75 Mn |
| Jul 31, 2023 | 8.75 Mn |
| Apr 30, 2023 | 6.84 Mn |
| Apr 30, 2023 | 6.84 Mn |